Implementation gaps for asthma prevention and control

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/297984

Lähdeviite

Tanno , L K , Haahtela , T , Calderon , M A , Cruz , A , Demoly , P & Joint Allergy Academies 2017 , ' Implementation gaps for asthma prevention and control ' , Respiratory Medicine , vol. 130 , pp. 13-19 . https://doi.org/10.1016/j.rmed.2017.07.006

Julkaisun nimi: Implementation gaps for asthma prevention and control
Tekijä: Tanno, Luciana K.; Haahtela, Tari; Calderon, Moises A.; Cruz, Alvaro; Demoly, Pascal; Joint Allergy Academies
Tekijän organisaatio: Clinicum
Department of Dermatology, Allergology and Venereology
University of Helsinki
HUS Inflammation Center
Päiväys: 2017-09
Kieli: eng
Sivumäärä: 7
Kuuluu julkaisusarjaan: Respiratory Medicine
ISSN: 0954-6111
DOI-tunniste: https://doi.org/10.1016/j.rmed.2017.07.006
URI: http://hdl.handle.net/10138/297984
Tiivistelmä: Asthma and allergic diseases can start in childhood and persist throughout life, but could also be manifested later, at any time for still misunderstood reasons. They are major chronic multifactorial respiratory diseases, for which prevention, early diagnosis and treatment is recognized as a priority for the Europe's public health policy and the United Nations. Given that allergy triggers (including infections, rapid urbanization leading to loss in biodiversity, pollution and climate changes) are not expected to change in a foreseeable future, it is imperative that steps are taken to develop, strengthen and optimize preventive and treatment strategies. Currently there are good treatments for asthma, several risk factors are known (e.g., allergies, rhinitis, tobacco smoke) and tools to control the disease have been developed. However, we are still uncertain how to prevent patients from developing asthma and allergic diseases. In this paper, we list the positive and negative experiences in this field as well as analyze the missing links in the process. This critical analysis will be the basis of setting-up an effective program for prevention and making, a process labeled as "implementation gaps". (C) 2017 Elsevier Ltd. All rights reserved.
Avainsanat: Allergy
Asthma
Prevention
Treatment
World health organization (WHO)
HYPERSENSITIVITY CONDITIONS SECTION
PRESCHOOL-CHILDREN
INTERNATIONAL CLASSIFICATION
INHALED CORTICOSTEROIDS
CHILDHOOD ASTHMA
CONTROLLED-TRIAL
YOUNG-CHILDREN
DISEASES
INTERMITTENT
ALLERGY
3121 General medicine, internal medicine and other clinical medicine
Vertaisarvioitu: Kyllä
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: publishedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
1_s2.0_S0954611117301932_main.pdf 991.2KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot